Integrating Population Health Strategies into Primary Care: Impact on Outcomes and Hospital Use for Low-Income Adults.

Chronic Disease Health Disparities Low-Income Patient-Centered Medical Home Population Health Uninsured

Journal

Ethnicity & disease
ISSN: 1945-0826
Titre abrégé: Ethn Dis
Pays: United States
ID NLM: 9109034

Informations de publication

Date de publication:
2022
Historique:
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 4 5 2022
Statut: epublish

Résumé

Our objectives were two-fold: 1) To evaluate the benefits of population health strategies focused on social determinants of health and integrated into the primary care medical home (PCMH) and 2) to determine how these strategies impact diabetes and cardiovascular disease outcomes among a low-income, primarily minority community. We also investigated associations between these outcomes and emergency department (ED) and inpatient (IP) use and costs. Retrospective cohort. Community-based PCMH: Baylor Scott & White Health and Wellness Center (BSW HWC). All patients who attended at least two primary care visits at BSW HWC within a 12-month time span from 2011-2015. Outcomes for patients participating in PCMH only (PCMH) as compared to PCMH plus population health services (PCMH+PoPH) were compared using electronic health record data. Diastolic and systolic blood pressure, hemoglobin A1c, ED visits and costs, and IP hospitalizations and costs were examined. From 2011-2015, 445 patients (age=46±12 years, 63% African American, 61% female, 69.5% uninsured) were included. Adjusted regression analyses indicated PCMH+PoPH had greater improvement in diabetes outcomes (prediabetes HbA1c= -.65[SE=.32], P=.04; diabetes HbA1c= -.74 [SE=.37], P<.05) and 37% lower ED costs than the PCMH group (P=.01). Worsening chronic disease risk factors was associated with 39% higher expected ED visits (P<.01), whereas improved chronic disease risk was associated with 32% fewer ED visits (P=.04). Integrating population health services into the PCMH can improve chronic disease outcomes, and impact hospital utilization and cost in un- or under-insured populations.

Identifiants

pubmed: 35497399
doi: 10.18865/ed.32.2.91
pii: ed.32.2.91
pmc: PMC9037647
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-100

Informations de copyright

Copyright © 2022, Ethnicity & Disease, Inc.

Déclaration de conflit d'intérêts

Competing Interests: Wesson: Paid consultant for Tricida, Inc (San Francisco) regarding metabolic acidosis (not related to this study)

Références

Lancet. 2016 Mar 5;387(10022):957-967
pubmed: 26724178
Acad Emerg Med. 2013 Oct;20(10):969-85
pubmed: 24127700
Am J Med Qual. 2017 May/Jun;32(3):246-253
pubmed: 27083505
Natl Health Stat Report. 2010 Oct 26;(29):1-20, 24
pubmed: 21086860
Ann Intern Med. 2013 Feb 5;158(3):169-78
pubmed: 24779044
Health Policy. 2018 Aug;122(8):900-907
pubmed: 29935730
Popul Health Manag. 2017 Feb;20(1):23-30
pubmed: 27563751
Ann Intern Med. 2020 Jan 21;172(2 Suppl):S50-S59
pubmed: 31958803
Am J Manag Care. 2018 Aug;24(8):368-375
pubmed: 30130029
Am J Hypertens. 2019 Mar 16;32(4):418-425
pubmed: 30590409
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
J Gen Intern Med. 2007 Apr;22(4):502-7
pubmed: 17372800
Health Aff (Millwood). 2018 Oct;37(10):1555-1561
pubmed: 30273041
JAMA. 2000 Oct 25;284(16):2061-9
pubmed: 11042754
Health Aff (Millwood). 2015 Jan;34(1):87-94
pubmed: 25561648
Neth J Med. 2014 Nov;72(9):462-6
pubmed: 25431391
Health Aff (Millwood). 2018 Apr;37(4):543-550
pubmed: 29608367
J Gen Intern Med. 2020 Aug;35(8):2304-2313
pubmed: 32096075
Adv Data. 2007 Jun 29;(386):1-32
pubmed: 17703794
Health Econ Rev. 2016 Dec;6(1):55
pubmed: 27924584
Diabetes Care. 2019 Sep;42(9):1661-1668
pubmed: 30940641
Am J Public Health. 2003 Dec;93(12):2051-4
pubmed: 14652333
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Ann Intern Med. 2017 Sep 19;167(6):424-431
pubmed: 28655034
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048

Auteurs

Heather Kitzman (H)

Baylor Scott & White Health and Wellness Center, Baylor Scott & White Health, Dallas, TX; Robbins Institute for Health Policy & Leadership, Baylor University, Waco, TX.

Kristen Tecson (K)

Baylor Scott & White Heart and Vascular Institute, Baylor Scott & White Health, Dallas, TX.

Abdullah Mamun (A)

Baylor Scott & White Health and Wellness Center, Baylor Scott & White Health, Dallas, TX; Robbins Institute for Health Policy & Leadership, Baylor University, Waco, TX.

Briget da Graca (B)

Baylor Scott & White Research Institute, Dallas, TX.

Samrat Yeramaneni (S)

Sarah Cannon Research Institute, Nashville, TN.

Kenneth Halloran (K)

Baylor Scott & White Health and Wellness Center, Baylor Scott & White Health, Dallas, TX; Robbins Institute for Health Policy & Leadership, Baylor University, Waco, TX.

Donald Wesson (D)

Baylor Scott & White Health and Wellness Center, Baylor Scott & White Health, Dallas, TX; Robbins Institute for Health Policy & Leadership, Baylor University, Waco, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH